Fondazione IRCCS Istituto Nazionale dei Tumori di Milano ( Site 0401)

Milan 20133

0 studies enrolling now · 1 studies all time

What they study most

Relapsed or Refractory Solid Tumors

Studies at this site

• A Study of Lenvatinib (MK-7902) in Pediatric Participants With Relapsed or Refractory Solid Malignancies (MK-7902-013/E7080) — Completed